Oren Gilad

APRE

Oren Gilad serves as President/CEO at Aprea Therapeutics, Inc. (APRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

6 trades

$55.4K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$55.4K

Companies Traded

APRE

Active Period

Mar 2024 – Jan 2026

6 total trades

Most Recent

Buy APRE

Jan 30, 2026 · $25.0K

Oren Gilad's Insider Trading at Aprea Therapeutics, Inc. (APRE)

Buys

6 · $55.4K

Sells

0 · $0.00

Total Shares Bought

37,500

Total Shares Sold

APRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jan 30, 2026↗	Buy	28,100	$0.89	$25.0K
Apr 3, 2025↗	Buy	5,500	$1.84	$10.1K
Oct 23, 2024↗	Buy	500	$3.92	$2.0K
Oct 15, 2024↗	Buy	250	$2.90	$725.00
Oct 10, 2024↗	Buy	1,150	$2.58	$3.0K
Mar 13, 2024↗	Buy	2,000	$7.29	$14.6K

Related Insiders

John P. Hamill

officer: SrVP/CFO/Prin Fin & Acct Ofcr

APREBuy · Jan 30, 2026

John P. Hamill

SrVP/CFO/Prin Fin & Acct Ofcr

APREBuy · Jan 30, 2026

Marc Duey

Director

APREBuy · Dec 10, 2025

Explore More Insider Trading Data

APRE Insider Trading Activity

View all insider trades at Aprea Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity